PFIZER: H1 net profit rose to Rs 517.72 crore, including a Rs 132.06 crore exceptional item

What happened

Pfizer reported first-half revenue of Rs 1,380.03 crore and net profit of Rs 517.72 crore. The title says first-half profit included a Rs 132.06 crore exceptional item. For the second quarter, revenue was Rs 726.86 crore and net profit was Rs 313.25 crore, also including that item.

Confirmed

Global impact / market context

The exceptional item is described as non-recurring, meaning it is not expected to repeat in the usual course. Investors comparing profit across periods may therefore separate it from ongoing earnings; without it, the reported first-half and quarterly profit figures would be lower, all else equal.

Analyst inference

The supplied figures show revenue and profit for both the first half and second quarter, but provide no prior-period comparison, forecast, or share-price response. The exceptional item makes recurring performance harder to judge from headline profit alone, while its source is identified as Minipress XL.

Analyst inference

What to watch

1. Check the original financial results for how Pfizer classified the Rs 132.06 crore Minipress XL item and whether it affected cash received or only reported profit. Analyst inference
2. Compare later results with these figures to see whether revenue and profit excluding exceptional items continue to grow; the supplied summary gives no prior-period trend. Analyst inference
3. Look for company details on Minipress XL and the exceptional item’s accounting treatment, since the summary provides no further explanation of its cause or recurrence. Analyst inference

Evidence

• Original source link unavailable